Ketamine
کتامین
🧠 Nervous SystemDissociative anaesthetic (NMDA antagonist)
Market / country: 🇺🇸 USA
Ketalar (US)
🧮 Dose calculator
General anaesthesia and premedication (adjunct) · Regimen source: FDA Ketamine · 2.2
- • Only by persons trained in anaesthesia, with airway management, oxygen and resuscitation available. FDA Ketamine · 2.1
- • Or 1–2 mg/kg at 0.5 mg/kg/min. Maintenance: repeat one-half to the full induction dose as needed. FDA Ketamine · 2.2
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Patients in whom a significant rise in blood pressure would be a serious hazard; hypersensitivity to ketamine. FDA Ketamine · 4
Warnings
- • Raised BP and heart rate; emergence reactions (hallucinations, dreams, delirium); respiratory depression with rapid injection; safety under 16 y not established. FDA Ketamine · 5FDA Ketamine · 8.4
Formulations
- 10 mg/mL multiple-dose vial — injection 🇺🇸 USA FDA Ketamine · 3
- 50 mg/mL multiple-dose vial — injection 🇺🇸 USA FDA Ketamine · 3
- 100 mg/mL multiple-dose vial — injection 🇺🇸 USA FDA Ketamine · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ketamine · 8.1
“Risk Summary Available data on the use of ketamine in pregnant women mostly describe its use at the time of cesarean section and have not identified a drug-associated risk of adverse maternal or fetal outcomes.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Ketamine · 8.2
“Risk Summary Published literature describe the presence of ketamine and its metabolite in human milk.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Ketamine · 8.4
“Safety and effectiveness in pediatric patients below the age of 16 have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Ketamine · 8.5
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA076092
- DailyMed (FDA label)FDA Ketamine
- MedlinePlus (NIH)Ketamine Injection
- WHO ATC/DDDN01AX03
- Darooyab (Iran)Ketamine
🇮🇷 Registered in Iran Darooyab · G-2671/Ketamine
Dosage forms with Iranian generic codes, per Darooyab.
- 00723 · KETAMINE HCL 50MG/ML 10ML VIAL · ویال کتامین هیدروکلراید ۵۰ میلیگرم / میلیلیتر ۱۰ میلیلیتر
- 51975 · KETAMINE (AS HYDROCHLORIDE) INJECTION PARENTERAL 50 mg/1mL 2 mL · فرآورده تزریقی کتامین (معادل هیدروکلراید) ۵۰ میلیگرم / ۱ میلیلیتر ۲ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Ketamine · 3FDA Ketamine · 2.2FDA Ketamine · 2.1FDA Ketamine · 4FDA Ketamine · 5FDA Ketamine · 8.4FDA Ketamine · SPL approval / marketing categoryFDA Ketamine · 8.1FDA Ketamine · 8.2FDA Ketamine · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2671/Ketamine
- Clinical review⚠ Unverified